Verrica Pharmaceuticals (NASDAQ:VRCA – Free Report) had its price target increased by HC Wainwright from $13.00 to $14.00 in a report released on Tuesday, Benzinga reports. They currently have a buy rating on the stock. Separately, Needham & Company LLC reiterated a buy rating and issued a $8.00 price objective on shares of Verrica Pharmaceuticals […]
Verrica Pharmaceuticals (NASDAQ:VRCA – Get Free Report)‘s stock had its “buy” rating reiterated by equities research analysts at Needham & Company LLC in a research report issued on Thursday, Benzinga reports. They currently have a $10.00 price target on the stock. Needham & Company LLC’s price objective would suggest a potential upside of 91.94% from […]